Inovio Pharmaceuticals INO
NASDAQ INO
$1.18 -0.03 (-2.48%)
At close: Aug 21, 2026 · 4:00 PM EDT

Inovio Pharmaceuticals (INO) Prepaid Assets (2010 - 2026)

Inovio Pharmaceuticals (INO) posted Prepaid Assets of $1.8 million for Q1 2026, down 32.65% sequentially from $2.6 million in Q4 2025, and down 20.85% YoY from $2.2 million in Q1 2025.

Inovio Pharmaceuticals (INO) Prepaid Assets (2010 - 2026) Analysis & Trends

Inovio Pharmaceuticals has reported Prepaid Assets for 17 years, with the latest figure at $1.8 million in Q1 2026.

  • Quarterly Prepaid Assets fell 20.85% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 20.85% YoY) and the FY2025 annual result came in at $2.6 million, down 29.75% from the prior year.
  • Prepaid Assets slipped to $1.8 million in Q1 2026 per INO's latest filing, from $2.6 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $58.0 million in Q3 2022 and troughed at $1.8 million in Q1 2026.
  • A 5-year average of $14.5 million and a median of $4.6 million in 2024 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2023 and 2024: Prepaid Assets sank 94.26% in 2023, then jumped 66.08% in 2024.
  • Over 5 years, Prepaid Assets stood at $50.1 million in 2022, then slumped by 89.2% to $5.4 million in 2023, then sank by 31.35% to $3.7 million in 2024, then dropped by 29.75% to $2.6 million in 2025, then plunged by 32.65% to $1.8 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $1.8 million, $2.6 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Inovio Pharmaceuticals 96.32 Mn 96.32 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 3.24 Mn
Mar 31, 2026 1.76 Mn
Dec 31, 2025 2.61 Mn
Sep 30, 2025 3.40 Mn
Jun 30, 2025 4.31 Mn
Mar 31, 2025 2.22 Mn
Dec 31, 2024 3.72 Mn
Sep 30, 2024 4.62 Mn
Jun 30, 2024 5.37 Mn
Mar 31, 2024 3.52 Mn
Dec 31, 2023 5.41 Mn
Sep 30, 2023 5.11 Mn
Jun 30, 2023 3.23 Mn
Mar 31, 2023 4.91 Mn
Dec 31, 2022 50.13 Mn
Sep 30, 2022 57.97 Mn
Jun 30, 2022 56.26 Mn
Mar 31, 2022 31.95 Mn
Dec 31, 2021 38.84 Mn
Sep 30, 2021 85.33 Mn